Sanofi gets rated buy today ... as it has been driving revenue from multiple products rather than a single magic drug.

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

To combat this, allergy medication Allegra created Allegra Airways, a website designed to help find and map real-time routes ...

US-based investment firm takes controlling stake in Opella, while France's government moves to ensure the company remains in ...

For its “Allegra Airways” campaign, the allergy medication brand used real-time pollen and air pollution data to find pockets ...

However, on October 17, J.P. Morgan maintained a Hold rating on Sanofi (Other OTC: SNYNF ... production and distribution of pharmaceutical products. It operates through the following business ...

With its decision, Sanofi joined peers Johnson & Johnson, Pfizer and GSK in hiving off businesses that sell over-the-counter medicines ... sell different types of products and services to both ...

Sanofi said it is the third-largest business worldwide in the market for over-the-counter medicines ... production volume for Opella's sensitive products in France," Armand added, including ...

The proposed sale had turned into a major political issue in France because Opella's products ... hands. Sanofi said the planned sale was part of its strategy to focus less on over-the-counter ...

which is the third-largest business in the world in the over-the-counter and vitamins, minerals & supplements market, according to Sanofi. The French pharma company said the deal, which saw CD&R ...

including details by product and quarter, are expected to be provided in the coming weeks. After the closing of the transaction, the share of results from the retained minority interest in Opella will ...